The atrial fibrillation patient community is invited to try out myLifeLog, an application just for tracking afib patient experiences. After entering your medical information, you can share it with your healthcare providers—either online or printed—and continue to update it from appointment to appointment. Learn more at: New Tool Lets You Track Your Atrial Fibrillation Patient …
Read More
New medical guidelines from the European Society of Cardiology (ESC) incorporating the latest afib research put Europe ahead of the U.S. when it comes to standardized treatment of atrial fibrillation. Stroke prevention and symptom relief are at the heart of the new ESC guidelines, which also make it clear that the risk of stroke for …
Read More
On the heels of the US FDA approving dabigatran, the long-awaited alternative to Coumadin (warfarin), comes word that Health Canada has as well. In Canada, dabigatran is known as PRADAX™. Because this is the first alternative to warfarin in Canada, it is big news for the afib community there. Learn more at: Health Canada Approves …
Read More
The long-awaited alternative to Coumadin (warfarin) has just been approved by the US FDA. The FDA just approved Pradaxa (dabigatran) for use by those with atrial fibrillation for preventing afib-related strokes. The FDA based approval on results of the RE-LY trial, which saw patients on Pradaxa having fewer strokes than those on warfarin. And Pradaxa …
Read More
A new mini maze procedure developed by Dr. John Sirak at Ohio State University is a promising new treatment for persistent atrial fibrillation as it closely replicates the "gold standard" Cox Maze III lesion set in the heart's left atrium. This “five box” thoracoscopic maze procedure may be better able to treat persistent AF specifically …
Read More
An FDA panel today unanimously recommended that the FDA approve dabigatran (Pradaxa) for reducing the risk of afib strokes. FDA approval is expected quickly, making this the first alternative to warfarin approved in the United States, and also the first atrial fibrillation approval for dabigatran. It is approved in over 70 countries for venous thromboembolisms …
Read More
Next Monday, September 20, 2010, StopAfib.org will be covering the FDA's hearing on dabigatran (Pradaxa), the new alternative to warfarin, and will be "live-tweeting" from the hearing. Get first reports as they happen by following @stopafib on Twitter. If you're already on Twitter, just follow us from the toolbar at the bottom of this page. …
Read More
Today is a very special day – it's the start of the fourth annual National Atrial Fibrillation Awareness Month. In celebration, StopAfib.org is kicking off a new initiative asking YOU to Take a Stand against Atrial Fibrillation and Stroke. We are launching the new Take a Stand video that shares important statistics about the impact …
Read More
Whether you're an atrial fibrillation patient or caregiver, or are just interested in learning more about afib, check out the new Get Started Learning About Atrial Fibrillation Guide at StopAfib.org. You'll find a wealth of information, including: what afib is and the problems it causes, including stroke and congestive heart failure information about an afib …
Read More
Here is an interesting webcast replay that you may want to check out if you're interested in having a catheter ablation or surgery for atrial fibrillation. In this webcast, cardiothoracic surgeon Dr. Andy C. Kiser and electrophysiologist Dr. Mark Landers, both of Moore Regional Hospital in Pinehurst, North Carolina, perform a Convergent Procedure. This procedure, …
Read More